{
  "question_stem": {
    "en": "A 50-year-old woman comes to the emergency department due to fever and abdominal pain. The patient has a history of type 2 diabetes mellitus. Her temperature is 38.3 C (101 F). Abdominal examination is notable for right upper quadrant tenderness to palpation that is worsened by deep inspiration. Laboratory studies show leukocytosis. An ultrasound of the abdomen reveals multiple gallstones and gallbladder wall thickening with pericholecystic fluid. Blood cultures are drawn, and surgical consultation is requested. The patient is initiated on intravenous piperacillin combined with tazobactam.",
    "zh": "一名50岁女性因发热和腹痛就诊于急诊科。患者有2型糖尿病病史。体温为38.3摄氏度（101华氏度）。腹部检查显示右上象限触诊压痛，深吸气时加重。实验室研究显示白细胞增多。腹部超声显示多发胆结石和胆囊壁增厚伴胆囊周围积液。抽取血培养，并要求外科会诊。患者开始静脉注射哌拉西林联合他唑巴坦。"
  },
  "question": {
    "en": "Which of the following is the most likely reason to use this drug combination in this patient?",
    "zh": "该患者使用这种药物组合最可能的原因是什么？"
  },
  "options": {
    "A": {
      "en": "Decrease bacterial inactivation of piperacillin",
      "zh": "减少细菌对哌拉西林的灭活"
    },
    "B": {
      "en": "Decrease renal clearance of piperacillin",
      "zh": "减少哌拉西林的肾清除"
    },
    "C": {
      "en": "Enhance bacterial penetration of piperacillin",
      "zh": "增强哌拉西林的细菌穿透力"
    },
    "D": {
      "en": "Increase bioavailability of piperacillin",
      "zh": "增加哌拉西林的生物利用度"
    },
    "E": {
      "en": "Provide additive antimicrobial activity",
      "zh": "提供叠加的抗菌活性"
    }
  },
  "correct_answer": "A",
  "explanation": {
    "en": "This patient's fever, leukocytosis, right upper quadrant pain with positive Murphy sign, and ultrasound findings (eg, gallstones, wall thickening, pericholecystic fluid) indicate ACUTE CHOLECYSTITIS. Antibiotic therapy is often administered to prevent secondary infection (eg, Escherichia coli, Klebsiella) due to biliary stasis, particularly in patients who have diabetes mellitus or immunodeficiency.\n\nThe penicillin family of antibiotics (eg, piperacillin) contains a beta-lactam ring, which inhibits peptidoglycan cross-linking and causes bacterial cell wall disruptions. Resistance is often due to beta-lactamase, a bacterial enzyme that hydrolyzes and inactivates the beta-lactam ring. The coadministration of a beta-lactamase inhibitor such as tazobactam prevents beta-lactamase producing organisms from inactivating penicillins, which extends their spectrum of activity (broadens the range of microbes that can be treated).\n\n(Choice B) Probenecid, a uricosuric agent used for hyperuricemia with gout, blocks the renal tubular excretion of penicillins and cephalosporins and is sometimes used to increase their serum level or prolong their half-life.\n\n(Choice C) Aminoglycosides inhibit bacterial protein synthesis by blocking the 30S ribosomal subunit. Penicillins are often coadministered with aminoglycosides to aid in their entry into the cell (penicillins disrupt the cell wall, which allow aminoglycosides to penetrate the bacteria).\n\n(Choice D) Piperacillin is always administered intravenously so bioavailability is 100%. Tazobactam inhibits beta-lactamase; it does not alter piperacillin metabolism or excretion.\n\n(Choice E) Additive antimicrobial activity occurs when 2 different antibiotic classes are used in combination, such as a fluoroquinolone (DNA gyrase inhibitor) with vancomycin (cell wall synthesis inhibitor). Beta-lactamase inhibitors block an enzyme that destroys penicillins; they do not independently provide antimicrobial activity so they are always used in combination with penicillin-class agents.",
    "zh": "该患者的发热、白细胞增多、右上象限压痛伴墨菲征阳性以及超声检查结果（如胆结石、壁增厚、胆囊周围积液）表明为急性胆囊炎。通常给予抗生素治疗以预防继发感染（如大肠杆菌、克雷伯菌），这与胆汁淤滞有关，尤其是在患有糖尿病或免疫缺陷的患者中。\n\n青霉素类抗生素（如哌拉西林）含有β-内酰胺环，可抑制肽聚糖交联并导致细菌细胞壁破坏。耐药性通常是由于β-内酰胺酶，这是一种细菌酶，可水解并灭活β-内酰胺环。联合使用β-内酰胺酶抑制剂（如他唑巴坦）可防止产生β-内酰胺酶的微生物灭活青霉素，从而扩大其活性谱（扩大可治疗的微生物范围）。\n\n（选项 B）丙磺舒是一种用于痛风高尿酸血症的促尿酸药物，可阻断青霉素和头孢菌素的肾小管排泄，有时用于增加其血清水平或延长其半衰期。\n\n（选项 C）氨基糖苷类药物通过阻断30S核糖体亚基来抑制细菌蛋白质合成。青霉素通常与氨基糖苷类药物联合使用，以帮助其进入细胞（青霉素破坏细胞壁，从而使氨基糖苷类药物能够穿透细菌）。\n\n（选项 D）哌拉西林总是静脉给药，因此生物利用度为100%。他唑巴坦抑制β-内酰胺酶；它不改变哌拉西林的代谢或排泄。\n\n（选项 E）当联合使用两种不同的抗生素类别时，会发生叠加抗菌活性，例如氟喹诺酮类药物（DNA促旋酶抑制剂）与万古霉素（细胞壁合成抑制剂）。β-内酰胺酶抑制剂阻断破坏青霉素的酶；它们不能独立提供抗菌活性，因此总是与青霉素类药物联合使用。"
  },
  "summary": {
    "en": "This question tests knowledge of antibiotic resistance mechanisms, specifically beta-lactamase production, and the rationale for using beta-lactamase inhibitors in combination with penicillins.\n\nThe key to solving this question is recognizing the patient's presentation as acute cholecystitis, understanding the mechanism of action of penicillins, and knowing how bacteria develop resistance through beta-lactamase production. The role of beta-lactamase inhibitors in preventing antibiotic inactivation is crucial.",
    "zh": "本题考察对抗菌素耐药机制（特别是β-内酰胺酶的产生）的了解，以及联合使用β-内酰胺酶抑制剂与青霉素的原理。\n\n解决本题的关键在于识别患者的临床表现为急性胆囊炎，了解青霉素的作用机制，并了解细菌如何通过β-内酰胺酶的产生而产生耐药性。β-内酰胺酶抑制剂在防止抗生素失活方面的作用至关重要。"
  },
  "tags": "Acute cholecystitis; Antibiotic resistance; Beta-lactamase; Piperacillin; Tazobactam; Infectious disease; Gastroenterology; Antimicrobial therapy",
  "category": "Micro",
  "question_id": "1091",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\1091",
  "extracted_at": "2025-11-05T14:49:39.925417",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:04:40.961932",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}